How We Are Thinking About Next Week's Earnings

Heading into a busy EPS week (again) we offer the following quick views on how we would be positioned into and following next week’s EPS results. Most of these comments represent shorter duration ideas or simply an indication that we don’t see anything to do in the short-term.  We know these comments aren’t for everyone, but in addition to shorter duration ideas we have taken the opportunity to discuss some long-term views that are (hopefully) of interest to shareholders with a longer duration.

 

Since nothing in staples (or the market) goes down for long (see our short CL call and today's "follow through"), we have looked hard for places where investors can generate some alpha on the short side - where we see risk to the multiple or EPS or both.  The two next week that we have are admittedly lower conviction - LO and CHD, but if you have to be short something....



February 4th



CLX – We would be short this name if we had a clear view on EPS weakness this quarter (we don’t).  The multiple (18.4x ’13) doesn’t make sense to us when we look at it in terms of the company’s long-term top line and EPS growth profile.  We have a $0.01 beat for the quarter.



February 5th



HAIN – Business momentum remains intact but we would prefer to own BNNY at the right price rather than the aggregation of tail brands and subpar management that is HAIN.



EL – This one is a little tricky.  We have a high multiple (24x ’13), a deceleration in constant currency organic growth in the last quarter and some conflicting laterals (RDEN/bad, Shiseido/bad, and LVMH/good).  LVMH is the best lateral in our view, so we think the top line will be fine (+7%).  We don’t have to do anything so we won’t do anything.



CHD – This is another name that we want to be short, except in this case we would take in a small short position.  The multiple is aggressive (20.8x ’13) and we see some risk to 2013 numbers based on what PG is saying and doing, so our view is take a small short in and stick with it.



K – Valuation is as reasonable as you will find in staples, 15.8x, and we see upside to this quarter’s result.  Guidance should encompass consensus, so we think you can be long for the print.



ADM – We like the name here, but no clear view on EPS.  Modeling out the quarters is probably better done by rolling chicken bones that using Excel, but any weakness associated with the quarter is an opportunity.  For the record, we do have a model, and we are $0.04 below consensus.



February 6th



SMG – No view into quarter as it is a seasonally unimportant quarter.  The fun starts when spring starts.



February 7th



CCE – We just heard from the company back in December, so little risk to numbers.  Fine to own, quarter won’t likely be a catalyst in either direction.



PM – This is another tough one as we remain below consensus for 2013.  However, the multiple (15.2x) versus the top line growth rate is compelling versus other staples names.  Recent move in the Euro helps, recent move in the Yen hurts.  Until we can see a clearer path to EPS upside, we will trade from the short side.



IFF – Volume trends from PG and Unilever are constructive, multiple is not (17.7x). Do nothing.



KRFT – We like the management and margin opportunity story here, but we like it lower.  Risk/reward range in the short term is $44 – $52; at $47 we do nothing.



February 8th



RAI – Our view is to trade the domestic tobacco names from the short side, but since we are modeling a small $0.02 beat by RAI in Q4 and the growth rate in 2013 (6%) seems reasonable, we will watch the print.



LO – We see some risk to Q4 consensus EPS of $0.76, so we can abide by a small short position.



BG – This is the same theme as ADM (global agricultural play) but with a better view on EPS, fine to own into Q and fine to buy on weakness.



Have a good weekend and be careful out there.



Call with questions,

 

Rob


Another French Revolution?

"Don't be complacent," writes Hedgeye Managing Director Neil Howe. "Tectonic shifts are underway in France. Is there the prospect of the new Sixth Republic? C'est vraiment possible."

read more

Cartoon of the Day: The Trend is Your Friend

"All of the key trending macro data suggests the U.S. economy is accelerating," Hedgeye CEO Keith McCullough says.

read more

A Sneak Peek At Hedgeye's 2017 GDP Estimates

Here's an inside look at our GDP estimates versus Wall Street consensus.

read more

Cartoon of the Day: Green Thumb

So far, 64 of 498 companies in the S&P 500 have reported aggregate sales and earnings growth of 6.1% and 16.8% respectively.

read more

Europe's Battles Against Apple, Google, Innovation & Jobs

"“I am very concerned the E.U. maintains a battle against the American giants while doing everything possible to sustain so-called national champions," writes economist Daniel Lacalle. "Attacking innovation doesn’t create jobs.”

read more

An Open Letter to Pandora Management...

"Please stop leaking information to the press," writes Hedgeye Internet & Media analyst Hesham Shaaban. "You are getting in your own way, and blowing up your shareholders in the process."

read more

A 'Toxic Cocktail' Brewing for A Best Idea Short

The first quarter earnings pre-announcement today is not the end of the story for Mednax (MD). Rising labor costs and slowing volume is a toxic cocktail...

read more

Energy Stocks: Time to Buy? Here's What You Need to Know

If you're heavily-invested in Energy stocks it's been a heck of a year. Energy is the worst-performing sector in the S&P 500 year-to-date and value investors are now hunting for bargains in the oil patch. Before you buy, here's what you need to know.

read more

McCullough: ‘My 1-Minute Summary of My Institutional Meetings in NYC Yesterday’

What are even some of the smartest investors in the world missing right now?

read more

Cartoon of the Day: Political Portfolio Positioning

Leave your politics out of your portfolio.

read more

Jim Rickards Answers the Hedgeye 21

Bestselling author Jim Rickards says if he could be any animal he’d be a T-Rex. He also loves bonds and hates equities. Check out all of his answers to the Hedgeye 21.

read more

Amazon's New 'Big Idea': Ignore It At Your Own Peril

"We all see another ‘big idea’ out of Amazon (or the press making one up) just about every day," writes Retail Sector Head Brian McGough. "But whatever you do, DON’T ignore this one!"

read more